article thumbnail

CDC Says US Will Transition to Trivalent Vaccines Next Flu Season

Drug Topics

Since changes in vaccine composition can sometimes lead to confusion or misinformation, effective communication is crucial to promote vaccine uptake.

Vaccines 200
article thumbnail

Fragmented Policy, Insurance Landscape Challenges Newly Approved Vaccines

Drug Topics

Innovation in the vaccine area continues. In 2023, the FDA approved six vaccines, including several important firsts. But they face a difficult landscape where federal policies dictate coverage.

Vaccines 184
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Vaccine Innovation Continued in 2023 with Several Important Approvals

Drug Topics

In 2023, the FDA approved six vaccines, including 2 for respiratory syncytial virus (RSV), and the first vaccine to prevent the mosquito-borne virus chikungunya.

Vaccines 187
article thumbnail

HPV vaccine study finds zero cases of cervical cancer among women vaccinated before age 14

STAT

A historic new study out of Scotland shows the real-world impact of vaccines against the human papillomavirus: The country has detected no cases of cervical cancer in women born between 1988-1996 who were fully vaccinated against HPV between the ages of 12 and 13.

Vaccines 145
article thumbnail

FDA advisory panel recommends a streamlined flu vaccine for next fall

STAT

When Americans line up for flu vaccines next fall, they will almost certainly be getting vaccines that no longer contain protection against a family of flu viruses that appears to be extinct.

Vaccines 129
article thumbnail

Flu Vaccine May Protect Against Heart Attack, Cardiovascular Events

Drug Topics

Study authors recommend that healthcare personnel consider prioritizing influenza vaccination for patients with recent cardiovascular diseases (CVDs) in light of new evidence.

Vaccines 232
article thumbnail

RSV Vaccine Coverage Similar to Flu Could Reduce Illness, Cost Burden

Drug Topics

A model showed that if a vaccine coverage of 66% were achieved—similar to flu vaccination coverage—it could have a budget impact of $6.48 billion over the first RSV season.

Vaccines 198